For the Inventor, By the Inventor

Enter assignee name

Warren, NJ, United States of America

Anthrogenesis Corporation

USPTO Granted Patents = 64

% Expired Patents = 32.8

CIPO Patents = 89

EPO Patents = 31

Trademarks = 3

Forward Citations = 2,074

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Robert J Hariri (43 out of 65 patents)

James W Edinger (22 out of 30 patents)

Qian Ye (16 out of 22 patents)

4. Mohammad A Heidaran (11 out of 19 patents)

5. Xiaokui Zhang (10 out of 16 patents)

6. Jia-Lun Wang (9 out of 13 patents)

7. Vanessa R Voskinarian-Berse (9 out of 11 patents)

8. Lin Kang (8 out of 10 patents)

9. Andrew L Zeitlin (7 out of 26 patents)

10. Stewart Abbot (6 out of 15 patents)

11. Kristen S Labazzo (5 out of 8 patents)

12. Ajai Pal (5 out of 6 patents)

13. Eric Law (5 out of 7 patents)

14. Ryhor Harbacheuski (5 out of 5 patents)

15. RoseAnn Murray (5 out of 5 patents)

Core Competencies:

Placental Stem Cells

Natural Killer Cells

Collagen Compositions

Immunomodulation

Bone Defects

Erythrocytes Production

Tumor Suppression

Placenta-derived Cells

Tissue Matrices

Cytotherapeutics

Inflammatory Diseases

Cord Blood Collection

64 patents: Sort by Forward Citations

1. 9770488 - Human placental collagen compositions, and methods of making and using the same (2017-09-26),

2. 9763983 - Natural killer cells from placenta (2017-09-19),

3. 9725694 - Composition for collecting and preserving placental stem cells and methods of using the composition (2017-08-08),

4. 9598669 - Composition for collecting placental stem cells and methods of using the composition (2017-03-21),

5. 9575054 - Identification of antitumor compounds using placenta (2017-02-21),

6. 9539288 - Immunomodulation using placental stem cells (2017-01-10),

7. 9464274 - Methods of generating natural killer cells (2016-10-11),

8. 9387283 - Method of collecting placental stem cells (2016-07-12),

9. 9364585 - Methods for collecting and using placenta cord blood stem cells (2016-06-14),

10. 9339520 - Methods and compositions for treatment of bone defects with placental cell populations (2016-05-17),

11. 9255248 - Method of producing erythrocytes without feeder cells (2016-02-09),

12. 9254302 - Angiogenesis using placental stem cells (2016-02-09),

13. 9216200 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells (2015-12-22),

14. 9200253 - Method of producing erythrocytes (2015-12-01),

15. 9149569 - Treatment of diseases or disorders using placental stem cells (2015-10-06),

Anthrogenesis Corporation, based in Warren, NJ, specializes in the innovative application of placental stem cells for therapeutic purposes. The company focuses on developing advanced solutions in immunomodulation, tumor suppression, and the treatment of bone defects. Its research encompasses the utilization of placenta-derived cells, natural killer cells, and collagen compositions, aiming to enhance erythrocyte production and improve health outcomes. Through its cutting-edge technologies, Anthrogenesis is positioned at the forefront of regenerative medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

64 Patents

#3 in Warren, NJ

#239 in New Jersey

#5,677 in US

#11,463 in the World

Warren, NJ, United States of America

Anthrogenesis Corporation

Forward Citations = 2,074

56 inventors:

Robert J Hariri (43 out of 65 patents)

James W Edinger (22 out of 30 patents)

Qian Ye (16 out of 22 patents)

4. Mohammad A Heidaran (11 out of 19 patents)

5. Xiaokui Zhang (10 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…